HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maarten Boers Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2019Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.
4/2012The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients.
8/2007Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maarten Boers Research Topics

Disease

94Rheumatoid Arthritis
04/2024 - 02/2002
10Rheumatic Diseases (Rheumatism)
06/2022 - 12/2012
9Arthritis (Polyarthritis)
01/2021 - 03/2007
8Inflammation (Inflammations)
06/2022 - 02/2009
7Neoplasms (Cancer)
06/2023 - 04/2002
6Pain (Aches)
01/2020 - 06/2014
5Psoriatic Arthritis
12/2023 - 08/2009
5Ankylosing Spondylitis
09/2023 - 08/2009
5Vasculitis (Vasculitides)
11/2015 - 10/2009
4Synovitis
12/2023 - 09/2015
4Infections
11/2023 - 01/2016
4Necrosis
01/2020 - 03/2013
4Osteoarthritis
09/2015 - 06/2008
3Autoimmune Diseases (Autoimmune Disease)
11/2023 - 09/2015
3COVID-19
06/2022 - 11/2021
3Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2014
3Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
03/2014 - 07/2011
3Ulcer
10/2007 - 04/2004
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2006 - 04/2002
2Psoriasis (Pustulosis Palmaris et Plantaris)
12/2023 - 01/2022
2Lymphoma (Lymphomas)
06/2023 - 11/2019
2Body Weight (Weight, Body)
01/2023 - 01/2023
2Axial Spondyloarthritis
01/2022 - 01/2020
2Arthralgia (Joint Pain)
01/2021 - 04/2016
2Fatigue
01/2020 - 02/2013
2Margins of Excision
02/2016 - 11/2007
2Carcinoma (Carcinomatosis)
02/2016 - 11/2007
2Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2015 - 07/2011
2Peptic Ulcer (Peptic Ulcers)
12/2007 - 10/2007
2Juvenile Arthritis (Juvenile Idiopathic Arthritis)
11/2007 - 02/2003
1Tuberculosis (Tuberculoses)
11/2023
1Opportunistic Infections (Opportunistic Infection)
11/2023
1Skin Neoplasms (Skin Cancer)
11/2023
1Melanoma (Melanoma, Malignant)
11/2023
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
10/2023
1Weight Loss (Weight Reduction)
01/2023
1Ankylosis
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Edema (Dropsy)
01/2023
1Weight Gain
01/2023
1Musculoskeletal Diseases (Musculoskeletal Disease)
06/2022
1AIDS-Related Complex (ARC)
06/2022
1Breakthrough Infections
06/2022
1Anterior Uveitis
08/2021

Drug/Important Bio-Agent (IBA)

33GlucocorticoidsIBA
04/2024 - 02/2004
16Antirheumatic Agents (DMARD)IBA
12/2023 - 05/2007
14Prednisolone (Predate)FDA LinkGeneric
10/2023 - 02/2002
12Abatacept (Orencia)FDA Link
11/2023 - 06/2006
12Methotrexate (Mexate)FDA LinkGeneric
11/2021 - 02/2002
11Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2020 - 02/2002
10Adalimumab (Humira)FDA Link
06/2021 - 09/2011
8Biomarkers (Surrogate Marker)IBA
01/2019 - 03/2007
6Etanercept (Enbrel)FDA Link
01/2020 - 02/2012
6Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2015 - 03/2007
5Prednisone (Sone)FDA LinkGeneric
11/2023 - 01/2012
5Tumor Necrosis Factor InhibitorsIBA
09/2023 - 03/2013
4C-Reactive ProteinIBA
06/2022 - 03/2007
4tocilizumab (atlizumab)FDA Link
01/2020 - 06/2010
4Rituximab (Mabthera)FDA Link
01/2020 - 04/2012
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2012 - 04/2002
3Infliximab (Remicade)FDA Link
01/2020 - 03/2014
3Biosimilar PharmaceuticalsIBA
01/2020 - 03/2014
3golimumabFDA Link
01/2020 - 03/2014
3Certolizumab PegolFDA Link
01/2020 - 03/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 08/2007
2secukinumabIBA
12/2023 - 01/2022
2LipidsIBA
01/2023 - 01/2018
2Glucose (Dextrose)FDA LinkGeneric
01/2023 - 05/2012
2AntibodiesIBA
06/2022 - 01/2022
2COVID-19 VaccinesIBA
05/2022 - 11/2021
2Rheumatoid FactorIBA
01/2021 - 04/2016
2sarilumabIBA
01/2020 - 06/2017
2baricitinibIBA
01/2020 - 06/2017
2tofacitinibIBA
01/2020 - 06/2017
2Janus Kinase InhibitorsIBA
01/2020 - 06/2017
2Leflunomide (Arava)FDA LinkGeneric
01/2020 - 06/2017
2Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2020 - 03/2007
2Janus KinasesIBA
01/2020 - 06/2017
2amsonic acid (DAS)IBA
01/2017 - 02/2016
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2015 - 03/2014
2AutoantibodiesIBA
09/2015 - 07/2011
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2023
1FluoridesIBA
01/2023
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2023
1AntigensIBA
06/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
06/2022
1(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA
01/2022
1N 30IBA
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1Immunomodulating AgentsIBA
01/2022
1Immunoglobulin G (IgG)IBA
11/2021
1VaccinesIBA
11/2021

Therapy/Procedure

44Therapeutics
09/2023 - 02/2002
2Phototherapy (Light Therapy)
01/2017 - 06/2015
2Laryngectomy
02/2016 - 11/2007
2General Anesthesia
02/2016 - 11/2007
2Radiotherapy
02/2016 - 11/2007
2Balneology
04/2015 - 06/2008
2Thoracotomy
04/2006 - 04/2002
1Ambulatory Care (Outpatient Care)
11/2022